DAVID
ANDALUZ OJEDA
Ikertzailea 2020-2020 tartean
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2022
-
ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points
Frontiers in Medicine, Vol. 9
-
Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study
International Journal of Molecular Sciences, Vol. 23, Núm. 23
2020
-
MR- proADM to detect specific types of organ failure in infection
European Journal of Clinical Investigation, Vol. 50, Núm. 6